Inventor
JAMES P. FANDL
Inventor
US
Overview
Patents· 12 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C12Nprimary
C12NMicroorganisms or enzymes36%
C07KPeptides27%
C12PFermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture6%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms6%
C12YEnzymes6%
G01NInvestigating or analysing materials by determining their chemical or physical properties6%
Y02PClimate change mitigation technologies in the production or processing of goods6%
A61KPreparations for medical, dental or toiletry purposes3%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations3%
PatentTitleYear
12,565,667CHO integration sites and uses thereof202612,528,883Compositions and methods for making antibodies based on use of expression-enhancing loci202612,503,520Compositions and methods for making antibodies based on use of an expression-enhancing locus202512,480,947Method for generating high affinity antibodies202512,054,751Fucosylation-deficient cells202411,808,766Method for generating high affinity antibodies202311,788,102CHO integration sites and uses thereof202311,560,550Fucosylation-deficient cells202311,530,277Compositions and methods for making antibodies based on use of an expression-enhancing locus202211,512,144Compositions and methods for making antibodies based on use of an expression-enhancing loci202211,370,843High affinity antibodies to human IL-6 receptor202211,268,109CHO integration sites and uses thereof2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2026Patents assigned to REGENERON PHARMA (12)· patent assignee history
2022Patents assigned to REGENERAN PHARMACEUTICALS INC (1)· patent assignee history
2022–2026Based in US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| REGENERON PHARMA | 12 | 2022–2026 |
| REGENERAN PHARMACEUTICALS INC | 1 | 2022 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 12 | 2022–2026 |